New patent for Amneal drug LYVISPAH

   April 3, 2024    Comments Off on New patent for Amneal drug LYVISPAH    Posted in: Patent Added

Annual Drug Patent Expirations for LYVISPAH Lyvispah is a drug marketed by Amneal and is included in one NDA. It is available from two suppliers. There are four patents protecting…
Source

Continue reading

New patent expiration for Msd Sub drug ISENTRESS HD

   April 3, 2024    Comments Off on New patent expiration for Msd Sub drug ISENTRESS HD    Posted in: Uncategorized

Annual Drug Patent Expirations for ISENTRESS+HD Isentress Hd is a drug marketed by Msd Sub Merck and is included in one NDA. It is available from nine suppliers. There are…
Source

Continue reading
Biotechblog